|
|
||||||||
Ann Thorac Surg 2005;79:1445-1453
© 2005 The Society of Thoracic Surgeons
a Department of Clinical Sciences, Colorado State University, Fort Collins, Colorado, USA
b Cardiovascular Surgery, Pompidou Hospital, University of Paris, Paris, France
* Address reprint requests to Dr Monnet, Department of Clinical Sciences, Colorado State University, Fort Collins, CO 80523, USA
eric.monnet{at}colostate.edu
Heart failure is the major cause of mortality in Western countries. Medical treatment of heart failure is associated with 50% survival at 5 years. Experimental models are required to better understand the progression of the disease and elaborate new therapy. Heart transplantation, left ventricular assist devices, artificial hearts, and cardiac bioassist techniques require animal models for testing and optimizing before they are implemented on human patients. The perfect model of heart failure that reproduces every aspect of the natural disease does not exist. Acute and chronic heart failure models have been developed to reproduce different aspect of the pathology.
This article has been cited by other articles:
![]() |
C. Bras-Silva, A. P. Fontes-Sousa, C. Moura, J. C. Areias, and A. F. Leite-Moreira Impaired Response to ETB Receptor Stimulation in Heart Failure: Functional Evidence of Endocardial Endothelial Dysfunction? Experimental Biology and Medicine, June 1, 2006; 231(6): 893 - 898. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |